Reduction rate of lymph node metastasis as a significant prognostic factor in esophageal cancer patients treated with neoadjuvant chemoradiation therapy

Diseases of the Esophagus

Volumn 20, Issue 2, 2007, Pages 94-101

  Aiko, Satoshi ^a   Yoshizumi, Y ^a   Ishizuka, T ^a   Sakano, T ^a   Kumano, I ^a   Sugiura, Y ^a   Maehara, T ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Chemoradiation therapy; Esophageal carcinoma; Lymph node metastasis; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HUMAN; LOW DRUG DOSE; LYMPH NODE METASTASIS; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME; UNIVARIATE ANALYSIS;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FLUOROURACIL; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOADJUVANT THERAPY; PROGNOSIS;

EID: 34147107478     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2006.00624.x     Document Type: Article

References (42)

1. Vogel SB, Mendenhall WM, Sombeck MD, Marsh R, Woodward ER. Downstaging of esophageal cancer after preoperative radiation and chemotherapy. Ann Surg 1995; 221: 685-95.
2. Tachibana M, Dhar DK, Kinugasa S et al. Esophageal cancer with distant lymph node metastasis: Prognostic significance of metastatic lymph node ratio. J Clin Gastroenterol 2000; 31: 318-22.
3. Jiao X, Krasna MJ, Sonett J et al. Pretreatment surgical lymph node staging predicts results of trimodality therapy in esophageal cancer. Eur J Cardio-Thorac Surg 2001; 19: 880-6.
4. Rice TW, Blackstone EH, Adelstein DJ et al. N1 esophageal carcinoma. The importance staging downstaging. J Thorac Cardiovasc Surg 2001; 121: 454-64.
5. Siewert JR, Stein HJ, Feith M, Bruecher BL, Bartels H, Fink U. Histologic tumor type is an independent prognostic parameter in esophageal cancer: Lessons from more than 1000 consecutive resections at a single center in the Western world. Ann Surg 2001; 234: 360-7.
6. Ando N, Ozawa S, Kitagawa Y, Shinozawa Y, Kitajima M. Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg 2000; 232: 225-32.
7. Maeta M, Koga S, Andachi H, Ishiguro M. Preoperative radiotherapy and intra-abdominal metastasis of the lymph node in the surgical treatment of carcinoma of the thoracic esophagus. Surg Gynecol Obstet 1987; 165: 235-8.
8. Itoh Y, Fuwa N, Matsumoto A, Asano A, Sasaoka M. Treatment results of chemoradiation for T1 esophageal cancer with lymph node metastases. Radiat Med 2000; 18: 81-5.
9. Ohara K, Hayakawa Y, Fuji H, Tatsuzaki H, Itai Y. Impact of biological clearance on tumor radioresponsiveness. Int J Rad Oncol Biol Phys 1996; 34: 389-93.
10. Ohara K, Okumura T, Tsuji H et al. Clearance of parenchymal tumors following radiotherapy: Analysis of hepatocellular carcinomas treated by proton beams. Radiother Oncol 1996; 41: 233-6.
11. Ohara K, Tatsuzaki H, Shimizu W, Sugahara S, Molotkova NG, Itai Y. Exfoliative tumor clearance following radiotherapy estimated by comparing radioresponse between primary esophageal cancer and its lymph node metastasis. Hepato-Gastroenterol 2001; 48: 1648-51.
12. Japanese Society for Esophageal Diseases. Guide Lines for the Clinical and Pathologic Studies on Carcinoma of the Esophagus, 9th edn. Tokyo: Kanehara & Co., LTD 1999.
13. Botet JF, Lightdale CJ, Zauber AG, Gerdes H, Urmacher C, Brennan MF. Preoperative staging of esophageal cancer: Comparison of endoscopic US and dynamic CT. Radiology 1991; 181: 419-25.
14. Lehr L, Rupp N, Siewert JR. Assessment of resectability of esophageal cancer by computed tomography and magnetic resonance imaging. Surgery 1988; 103: 344-50.
15. Takashima S, Takeuchi N, Shiozaki H et al. Carcinoma Esophagus: CT vs MR imaging in determining resectability. AJR AM J Roentgenol 1991; 156: 297-302.
16. Funai T, Osugi H, Higashino M, Kinoshita H. Estimation of lymph node metastasis by size in patients with intrathoracic oesophageal cancer. Br J Surg 2000; 87: 1234-9.
17. Mizowaki T, Nishimura Y, Shimada Y et al. Optimal size criteria of malignant lymph nodes in the treatment planning of radiotherapy for esophageal cancer: Evaluation by computed tomography and magnetic resonance imaging. Int J Rad Oncol Biol Phys 1996; 36: 1091-8.
18. Liang EY, Chan A, Chung SC, Metreweli C. Short communication: oesophageal tumour Volume measurement using spiral CT. Br J Radiol 1996; 69: 344-7.
19. Griffith JF, Chan AC, Chow LT et al. Assessing chemotherapy response of squamous cell oesophageal carcinoma with spiral CT. Br J Radiol 1999; 72: 678-84.
20. Thomas E, Crellin A, Harris K, Swift S, Montefiore DS. The role of endoscopic ultrasound (EUS) in planning radiotherapy target Volumes for oesophageal cancer. Radiother Oncol 2004; 73: 149-51.
21. Catalano MF, Sivak MV Jr, Rice T, Gragg LA, Van Dam J. Endosonographic features predictive of lymph node metastasis. Gastrointest Endosc 1994; 40: 442-6.
22. Nordsmark M, Overgaard M, Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol 1996; 41: 31-9.
23. Vanselow B, Eble MJ, Rudat V, Wollensack P, Conradt C, Dietz A. Oxygenation of advanced head and neck cancer: Prognostic marker for the response to primary radiochemotherapy. Otolaryngol Head Neck Surg 2000; 122: 856-62.
24. 2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol 1993; 26: 45-50.
25. Rudat V, Vanselow B, Wollensack P et al. Repeatability and prognostic impact of the pretreatment pO(2) histography in patients with advanced head and neck cancer. Radiother Oncol 2000; 57: 31-7.
26. Brizel DM, Sibley GS, Prosnitz LR, Scher RL, Dewhirst MW. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Rad Oncol Biol Phys 1997; 38: 285-9.
27. Rofstad EK, Sundfor K, Lyng H, Trope CG. Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis. Br J Cancer 2000; 83: 354-9.
28. Becker A, Hansgen G, Bloching M, Weigel C, Lautenschlager C, Dunst J. Oxygenation of squamous cell carcinoma of the head and neck: Comparison of primary tumors, neck node metastases, and normal tissue. Int J Rad Oncol Biol Phys 1998; 42: 35-41.
29. Mandard AM, Dalibard F, Mandard JC et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Cancer 1994; 73: 2680-6.
30. Dhar DK, Tachibana M, Kinukawa N et al. The prognostic significance of lymph node size in patients with squamous esophageal cancer. Ann Surg Oncol 2002; 9: 1010-16.
31. Komori T, Doki Y, Kabuto T et al. Prognostic significance of the size of cancer nests in metastatic lymph nodes in human esophageal cancers. J Surg Oncol 2003; 82: 19-27.
32. Ohtsu A, Boku N, Muro K et al. Definitive Chemoradiotherapy for T4 and/ or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol 1999; 9: 2915-21.
33. Murakami M, Kuroda Y, Okamoto Y et al. Neoadjuvant concurrent chemoradiotherapy followed by definitive high-dose radiotherapy or surgery for operable thoracic esophageal carcinoma. Int J Radiat Oncol Biol Phys 1998; 40: 1049-59.
34. Beseth BD, Bedford R, Isacoff WH, Holmes EC, Cameron RB. Endoscopic ultrasound does not accurately assess pathologic stage of esophageal cancer after neoadjuvant chemotherapy. Am Surg 2000; 66: 827-31.
35. Zuccaro G Jr, Rice T W, Goldblum J et al. Endoscopic ultrasound cannot determine the suitability of esophagectomy after aggressive chemotherapy for esophageal cancer. Am J Gastroenterol 1999; 94: 906-12.
36. Liao Z, Zhang Z, Jin J et al. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients. Int J Radiat Oncol Biol Phys 2004; 60: 1484-93.
37. Kawahara K, Maekawa T, Okabayashi K et al. The number of lymph node metastases influences survival in esophageal cancer. J Surg Oncol 1998; 67: 160-3.
38. Gu Y, Swisher SG, Ajani JA et al. The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation. Cancer 2006; 106: 1017-25.
39. Ancona E, Ruol A, Santi S et al. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: Final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone. Cancer 2001; 91: 2165-74.
40. Aoyama N, Koizumi H, Minamide J, Yoneyama K, Isono K. Prognosis of patients with advanced carcinoma of the esophagus with complete response to chemotherapy and/or radiation therapy: A questionnaire survey in Japan. Int J Clin Oncol 2001; 6: 132-7.
41. Jin J, Liao Z, Zhang Z et al. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 2004; 60: 427-36.
42. Ajani JA, Walsh G, Komaki R et al. Preoperative induction of CPT-11 and cisplatin chemotherapy followed by chemoradiotherapy in patients with locoregional carcinoma of the esophagus or gastroesophageal junction. Cancer 2004; 100: 2347-54.